Valeda Light Therapy: Now Available at the Eye Institute of Utah
Innovative New Treatment for Dry Age-Related Macular Degeneration (AMD)
The Eye Institute of Utah is excited to announce the arrival of Valeda® Light Delivery System—an FDA-authorized, non-invasive treatment for dry age-related macular degeneration (AMD). As a leader in advanced eye care, we are proud to offer this breakthrough technology to patients in Salt Lake City and beyond.
What Is Valeda?
Valeda is the first and only FDA-authorized device shown in clinical studies to improve visual function in people with dry AMD. It uses photobiomodulation (PBM)—a therapeutic application of low-level light—to support the health and function of retinal cells impacted by AMD.
How Valeda Works
Valeda delivers pulses of red, yellow, and near-infrared light to the retina in a precise, controlled manner. These wavelengths are absorbed by the mitochondria in retinal cells, helping to:
- Support energy production at the cellular level
- Reduce oxidative stress and inflammation
- Improve overall retinal performance
Treatments are comfortable, quick, and performed right here in our office. Most patients undergo multiple sessions over several weeks for optimal results.
Why This Is a Game-Changer for Dry AMD
Dry AMD is a progressive eye condition that can lead to serious vision changes over time. Until now, treatment options have been limited, offering little in the way of proactive care. Valeda represents a significant advancement—providing a new, research-backed option that may help slow disease progression and preserve vision.
“At the Eye Institute of Utah, we’re always looking for ways to bring the most advanced and meaningful treatments to our patients. Valeda gives us a powerful new tool in the fight against dry AMD.”
Dr. Zavodni, Medical Director
Find Out If Valeda Is Right for You
If you or someone you love has been diagnosed with dry AMD, we invite you to schedule a consultation to learn more about Valeda Light Therapy. This innovative treatment is now available at the Eye Institute of Utah—giving patients new hope for preserving their sight and quality of life.
